Clinical trial
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian…
NCT00005807 · Albert Einstein College of Medicine, Other · Completed
Key facts
| NCT number | NCT00005807 |
|---|---|
| Title | Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer |
| Official title | A Phase I Scientific Exploratory Study of Epothilone B Analog in Patients With Solid Tumors and Gynecological Malignancies |
| Acronym | BMS-247550 |
| Lead sponsor | Albert Einstein College of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Ovarian Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BMS-247550 |
| Enrollment | 40 |
| Start date | Jul 1, 2000 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: